U.S. Professional Services Stock News

NYSE:FRT
NYSE:FRTRetail REITs

Is Federal Realty (FRT) Using Asset Sales to Quietly Redefine Its Long‑Term Portfolio Strategy?

Federal Realty Investment Trust recently completed the sale of Misora Apartments, a 212-unit Class A residential community at Santana Row in San Jose, California, alongside the earlier disposition of Courthouse Center in Rockville, Maryland. These transactions, which have generated nearly US$475,000,000 in proceeds over recent quarters, highlight Federal Realty’s ongoing capital recycling program aimed at reinvesting in potentially higher-return properties while maintaining financial...
NYSE:VVX
NYSE:VVXAerospace & Defense

How Investors Are Reacting To V2X (VVX) Expanding Secure AI Partnerships And Reviving A US$4.30 Billion Contract

In recent weeks, V2X, Inc. has unveiled partnerships with Google Public Sector and Amazon to deploy secure AI, cloud, and smart warehousing technologies for U.S. defense, intelligence, and government logistics programs, alongside resuming work on its US$4.30 billions T-6 COMBS aircraft supply contract after a protest was denied. Together, these moves deepen V2X’s role at the intersection of advanced AI and long-duration government support contracts, expanding its reach across both...
NYSE:UAN
NYSE:UANChemicals

Quarterly Loss, Full‑Year Profit Guidance Might Change The Case For Investing In CVR Partners (UAN)

In January 2026, CVR Partners, LP issued earnings guidance for the past fourth quarter of 2025, projecting a net loss of US$14 million to US$7 million, while estimating full‑year 2025 net income of US$95 million to US$102 million. This contrast between an anticipated quarterly loss and a profitable full year highlights the company’s uneven earnings profile and the importance of timing in its results. We’ll now examine how this guidance, particularly the contrast between a quarterly loss and...
NYSE:MANE
NYSE:MANEPharmaceuticals

Assessing Veradermics (MANE) Valuation After Recent 3.6% Share Price Move

Veradermics stock in focus after recent price move Veradermics (MANE) drew fresh attention after a single day gain of about 3.6%, putting the US$38.48 share price and the company’s dermatology focused pipeline on more investors’ radar. See our latest analysis for Veradermics. The 3.6% one day share price return comes after a relatively muted 1.9% year to date share price return, suggesting interest around Veradermics is picking up only gradually rather than in a sharp momentum shift. If this...
NYSE:MPC
NYSE:MPCOil and Gas

Assessing Marathon Petroleum (MPC) Valuation After Strong Q4 2025 Earnings And Ongoing Buybacks

Marathon Petroleum (MPC) is back in focus after reporting fourth quarter 2025 results. The company posted net income of US$1,535 million and diluted earnings per share of US$5.12 on relatively steady quarterly revenue. See our latest analysis for Marathon Petroleum. The earnings release and ongoing buybacks come as the share price trades at US$203.0, with a 7 day share price return of 14.75% and year to date share price return of 22.93%, while the 5 year total shareholder return of 358.54%...
NYSE:ETN
NYSE:ETNElectrical

Assessing Eaton (ETN) Valuation After Strong Earnings And Positive 2026 Guidance

Eaton (ETN) is back in focus after reporting its fourth quarter and full year 2025 results along with fresh 2026 guidance, giving investors new data on sales, earnings and expected organic growth. See our latest analysis for Eaton. Eaton shares have been on a strong run, with the latest share price at $373.82 and a 1 month share price return of 15.2%, alongside a 1 year total shareholder return of 18.36%. The 5 year total shareholder return of 228.09% points to sustained momentum as investors...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

How DraftKings’ New Crypto.com Event Contracts Will Impact DraftKings (DKNG) Investors

In early February 2026, DraftKings Inc. announced an agreement with Crypto.com | Derivatives North America to broaden DraftKings Predictions, introducing the first player-specific sports event contracts for the NFL and NBA and expanding into additional sports under CFTC oversight. The collaboration also lays groundwork for future event contracts in politics, culture, and entertainment, positioning DraftKings Predictions as a broader federally regulated prediction platform beyond traditional...
NYSE:AXP
NYSE:AXPConsumer Finance

Assessing American Express (AXP) Valuation After Strong Results And A 16% Dividend Increase

Why American Express stock is back in focus American Express (AXP) is drawing fresh attention after reporting strong fourth quarter and full year 2025 results, issuing upbeat 2026 guidance, and lifting its quarterly dividend by 16%. See our latest analysis for American Express. These results and the 16% dividend lift come as American Express shares trade at US$359.15, with short term share price returns slightly softer in recent weeks while multi year total shareholder returns above 100%...
NasdaqCM:BLTE
NasdaqCM:BLTEPharmaceuticals

Belite Bio (BLTE) Valuation Check After Completing Enrollment In Pivotal DRAGON II Trial

Belite Bio (BLTE) completed enrollment of 60 adolescents in its global Phase 2/3 DRAGON II trial for tinlarebant in Stargardt disease type 1, marking a key clinical milestone that investors often watch closely. See our latest analysis for Belite Bio. The latest clinical milestone comes on top of a strong run in the shares, with Belite Bio’s 30 day share price return of 18.63% and 90 day share price return of 77.63%. Its 1 year total shareholder return of 249.18% and 3 year total shareholder...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Group (LCID) Is Up 5.5% After UBS Nearly Doubles Its Stake – Has The Bull Case Changed?

In the fourth quarter of 2025, UBS disclosed that it nearly doubled its stake in Lucid Group, purchasing 3.81 million additional shares to bring its total holding to 7.68 million shares. This move makes UBS one of Lucid’s largest institutional investors aside from Saudi Arabia’s Public Investment Fund, highlighting growing institutional interest in the electric-vehicle maker. With UBS’s increased ownership as a focal point, we’ll now examine what this means for Lucid Group’s investment...